Cleveland HeartLab completes $18.4-million financing round
CLEVELAND, Aug. 22, 2011 – Cleveland HeartLab Inc. (CHL), a leading specialty clinical laboratory and disease management company, today announced the completion of an $18.4-million Series B financing round. Excel Venture Management and HealthCare Ventures, both of Boston, led the round. The company’s existing investors also participated.
For the complete story click here